SCHEMBL4137951

SCHEMBL4137951

CN1CCN(c2ccc(CN3CC(=O)[N]C3=O)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHKA P35790 2/20 0.47
LSS P48449 1/20 0.45
NCF1 P14598 1/20 0.43
GAA P10253 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ALDH1A1 P00352 3/20 0.42
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41
ADRA2C P18825 1/20 0.41
GFER P55789 1/20 0.41
PTK2B Q14289 1/20 0.41
ESR2 Q92731 1/20 0.41
ACE2 Q9BYF1 1/20 0.40
SIRT6 Q8N6T7 1/20 0.40
MAP4K1 Q92918 1/20 0.39
POLB P06746 1/20 0.39
TLR7 Q9NYK1 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4151283 0.86 ALDH1A1 (0.41) CHKAGAAL3MBTL1ALDH1A1KMT2A
SCHEMBL11848182 0.77 SMN1; SMN2 (0.47) GAAALDH1A1KMT2AMAPTPOLB
SCHEMBL13924882 0.77 CHKA (0.49) CHKALSSNCF1GAAL3MBTL1
SCHEMBL4154502 0.76 ERCC1 (0.43) LSSALDH1A1KMT2AKDM4EMAPT
SCHEMBL4892237 0.74 EPHX2 (0.45) GAAL3MBTL1ALDH1A1KMT2APOLB
SCHEMBL27606228 0.70 CHKA (0.59) CHKALSSNCF1GAAL3MBTL1
SCHEMBL6473253 0.69 ALDH1A1 (0.65) CHKALSSNCF1GAAL3MBTL1
SCHEMBL178275 0.68 ALDH1A1 (0.63) CHKANCF1GAAL3MBTL1ALDH1A1
SCHEMBL18774112 0.67 CHKA (0.56) CHKANCF1GAAL3MBTL1ALDH1A1
SCHEMBL347427 0.67 CHKA (0.86) CHKANCF1GAAL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054467-A1 Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases BETSCHART CLAUDIA 2009-02-26 US disclosed
US-7452886-B2 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases NOVARTIS AG (CH) 2008-11-18 US disclosed
EP-1423391-B8 PYRROLO PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CYSTEIN PROTEASES NOVARTIS AG (CH) 2007-12-12 EP disclosed
EP-1423391-B1 PYRROLO PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CYSTEIN PROTEASES NOVARTIS AG (CH) 2006-05-17 EP disclosed
US-20050054851-A1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases NOVARTIS AG (CH) 2005-03-10 US disclosed
EP-1423391-A1 PYRROLO PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CYSTEIN PROTEASES Novartis AG (CH) 2004-06-02 EP disclosed
WO-2003020721-A1 PYRROLO PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CYSTEIN PROTEASES NOVARTIS AG (CH) 2003-03-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054851-A1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases CTSK, CTSS, CTSZ CHKA 854/4885LSS 3075/4885NCF1 895/4885
US-20090054467-A1 Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases CTSK, CTSS, CTSZ CHKA 854/4885LSS 3075/4885NCF1 895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.